Global Ganja Report

Questions about road safety have been a real concern as cannabis legalization has unfolded across 11 states, with medical marijuana laws in many more. But with several years of data to analyze, a new study finds no link between these policies and traffic fatalities.

In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.

Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."

CBD products are now everywhere—health-food emporia, pharmacies, truck-stops. And pursuant to the 2018 Farm Bill, they are now legal—as long as the CBD is derived from “hemp” as opposed to what has traditionally been called “marijuana.” Hemp, as legally defined, is cannabis with under 0.3% THC—the psychoactive component of the plant, responsible for the long-stigmatized “high.”

But even the hempiest hemp—rope, not dope, as they used to say—usually has some THC.

The autumn of 2019 saw the United States' first hemp harvest since effective prohibition of the crop under the strictures of the Marihuana Tax Act in 1937. These strictures were overturned in the Farm Bill signed into law by President Trump in the closing days of 2018. This harvest was looked to eagerly across much of rural America, as legal hemp had been plugged as a salvation for the nation's struggling farmers—and the soaring popularity of CBD appeared to provide a booming market. The fashionable cannabinoid had also been legalized by the 2018 Farm Bill—when derived from hemp, or cannabis with less than 0.3% THC.

Hemp’s Curious Cultural Trajectory

Now that hemp has finally arrived at its long-sought status as a legal crop and commodity, there is a sense of inevitability to its deviation from the utopian vision that animated the advocates who fought for it a generation ago.

A tension that has always existed between two currents in the subculture of hemp advocacy is increasingly weighted toward the more mundane—activists versus entrepreneurs, idealism versus pragmatism, agrarianism versus agribusiness. And finally the original paradigm of a crop with multitudinous uses as “food, fuel and fiber,” holding the potential to solve humanity’s ecological crisis, versus the hegemony of CBD.

Joe Biden's choice of running mate is Kamala Harris, who will bring a more progressive position on cannabis to the ticket. But if Harris today embraces legalization, she too has capitulated to the drug war establishment in the past—a reality her critics have been quick to exploit. A review of her record reveals an overall evolution toward a more enlightened stance.

Nancy Pelosi roused the ire of Mitch McConnell and anti-pot lobbyists when she defended inclusion of a measure to protect cannabis businesses in the House pandemic recovery bill. Does the science actually point to a therapeutic role for cannabis in treatment of COVID-19?

Equity programs for the legal cannabis industry in California are supposed to address the racial and social iniquities that were associated with cannabis prohibition. But finding the right implementation model has proved tricky. And as a recent controversy in Los Angeles indicates, the failure of such programs can have impacts that go beyond who is getting licenses for dispensaries.